Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Analysis of Optimal Spica Cast Duration Following Closed Reduction for Developmental Dysplasia of the Hip (DDH)

NCT06204068 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT06204068
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06204068 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Analysis of Optimal Spica Cast Duration Following Closed Reduction for Developmental Dysplasia of the Hip (DDH)
Lead sponsor
Yale University
Phase
Not applicable
Overall status
Withdrawn
Start date
May 31, 2025
Completion date
January 31, 2026
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dysplasia; hip